Question follow-through · 108527
Trade Agreements: USA
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of the UK-US Pharmaceuticals Deal concluded in December 2025 on (a) NHS procurement costs and (b) consumer access to affordable medicines befor
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 26 Jan 2026
- Target answer date
- 28 Jan 2026
- Answer
- 2 Feb 2026 · 7 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Medical Treatments · 3 Feb 2026
- Medical Treatments: Finance · 3 Feb 2026
- Medical Treatments · 3 Feb 2026
- Endometriosis: Training · 20 Feb 2026
- Department of Health and Social Care: Personnel Management · 23 Feb 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
26 Jan 2026
Question tabled
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of the UK-US Pharmaceuticals Deal concluded in December 2025 on (a) NHS procurement costs and (b) consumer access to affordable medicines befor
28 Jan 2026
Target answer date
Date supplied by the official written-questions record.
2 Feb 2026
Answer published
There are no current plans to publish an impact assessment or modelling on the United Kingdom and United States’ pharmaceutical trade deal. Further detail on the deal will be shared in due course.Tens of thousands of National Health Service patients will ...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Medical Treatments
3 Feb 2026 · To ask the Secretary of State for Health and Social Care, how many times NHS England’s Clinical Priorities Advisory Group Prioritisation meeting happens each year; and when the next meeting will be.
Medical Treatments: Finance
3 Feb 2026 · To ask the Secretary of State for Health and Social Care, what level of recurrent funding has been identified to fund new treatments through NHS England’s Clinical Priorities Advisory Group Prioritisation meeting.
Medical Treatments
3 Feb 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the backlog for NHS England’s Clinical Priorities Advisory Group Prioritisation meeting.
Endometriosis: Training
20 Feb 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that endometriosis is adequately covered in the education and training of healthcare practitioners.
Department of Health and Social Care: Personnel Management
23 Feb 2026 · To ask the Secretary of State for Health and Social Care, how many directors with responsibility for human resources are employed across their department and its executive agencies; and how many of those directors hold professional HR qualifications from
Diabetes: Women
3 Mar 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of women's health pathways in providing structured nutritional and metabolic support to women experiencing early endocrine and metabolic symptoms before
Medical Treatments: Finance
17 Mar 2026 · To ask the Secretary of State for Health and Social Care, what level of recurrent funding has been identified by NHS England to fund the recommendations of new treatments considered by NHS England’s next Clinical Priorities Advisory Group Prioritisation m
Medical Treatments
17 Mar 2026 · To ask the Secretary of State for Health and Social Care, if NHS England Specialised Commissioning will consider a second prioritisation meeting this year of the Clinical Priorities Advisory Group to reduce the 20 treatments currently being considered, in
Polio: Sewers
10 Apr 2026 · To ask the Secretary of State for Health and Social Care, what assessment the UK Health Security Agency has made of the public health risk associated with poliovirus detections in wastewater surveillance systems in the last 12 months.
Skin Diseases: Steroid Drugs
16 Apr 2026 · To ask the Secretary of State for Health and Social Care, whether he plans to introduce updated clinical (a) guidance and (b) training for healthcare professionals on the identification and management of Topical Steroid Withdrawal.
Skin Diseases: Steroid Drugs
16 Apr 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve awareness and clinical recognition of Topical Steroid Withdrawal among GPs, dermatologists and other healthcare professionals.
Skin Diseases: Steroid Drugs
16 Apr 2026 · To ask the Secretary of State for Health and Social Care, what steps are being taken to ensure patients prescribed topical corticosteroids are informed of potential risks, including withdrawal reactions.